RxDoctor Payments Data

Solange Adangwa, NP

Psychiatric/Mental Health · Martinsburg, WVNPI 1891051025

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 26.9% of the total. 2025 is the largest year on record at $806, more than ten times the $78 reported in 2023.

$1,145in general payments, 2019–2025

Across 56 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$308
  • Neurocrine Biosciences, Inc.$186
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$156
  • Lundbeck LLC$143
  • Teva Pharmaceuticals USA, Inc.$125
  • Alkermes, Inc.$69
  • plus $158 from 4 others

What the payments were for

  • Food & beverage$1,145100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,145 in reported general payments places this provider in the 65th percentile of 142 psychiatric/mental health providers in West Virginia.

See all psychiatric/mental health providers in West Virginia

Medicare billing

Part B allowed, 2024
$20,398
Medicare patients
68
Services billed
226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clonazepam15$36

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Martinsburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →